Cargando…

Image-Enhanced Bronchoscopic Evaluation of Bronchial Mucosal Microvasculature in COPD [Corrigendum]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743614/ https://www.ncbi.nlm.nih.gov/pubmed/35023910 http://dx.doi.org/10.2147/COPD.S355297

Ejemplares similares

Image-enhanced bronchoscopic evaluation of bronchial mucosal microvasculature in COPD
por: Metwally, Eman M, et al.
Publicado: (2016)

Patient Selection for Bronchoscopic Lung Volume Reduction [Corrigendum]
Publicado: (2020)

Efficacy of bronchoscopic lung volume reduction: a meta-analysis [Corrigendum]
Publicado: (2014)

The role of the bronchial microvasculature in the airway remodelling in asthma and COPD
por: Zanini, Andrea, et al.
Publicado: (2010)

Endoscopic bronchial valve treatment: patient selection and special considerations [Corrigendum]
Publicado: (2015)

Disrupted Expression of Circadian Clock Genes in Patients with Bronchial Asthma [Corrigendum]
Publicado: (2021)

COPD management costs according to the frequency of COPD exacerbations in UK primary care [Corrigendum]
Publicado: (2014)

Corrigendum to “Recommendations for Diagnosis and Management of Osteoporosis in COPD Men”
por: Mazokopakis, Elias E., et al.
Publicado: (2017)

Corrigendum to: 204. Mucosal Cytokine Profiles in Children with COVID-19
por: Quintero, Ana M, et al.
Publicado: (2022)

Characteristics of Induced-Sputum Inflammatory Phenotypes in Adults with Asthma: Predictors of Bronchial Eosinophilia [Corrigendum]
Publicado: (2023)

Bronchiectasis in COPD patients: more than a comorbidity? [Corrigendum]
Publicado: (2019)

Russian guidelines for the management of COPD: algorithm of pharmacologic treatment [Corrigendum]
Publicado: (2019)

Nasal high-flow in acute hypercapnic exacerbation of COPD [Corrigendum]
Publicado: (2019)

Repetitive Saliva Swallowing Test Predicts COPD Exacerbation [Corrigendum]
Publicado: (2021)

Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis [Corrigendum]
Publicado: (2020)

Sinonasal Symptoms in COPD: Burden and Associations with Clinical Markers of Disease [Corrigendum]
Publicado: (2022)

Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD [Corrigendum]
Publicado: (2014)

Predicting frequent COPD exacerbations using primary care data [Corrigendum]
Publicado: (2018)

The Relationship Between Morning Symptoms and the Risk of Future Exacerbations in COPD [Corrigendum]
Publicado: (2021)

Reduced Variability of Endurance Time in New Protocols for Exercise Tests in COPD [Corrigendum]
Publicado: (2021)

The Association Between Cognitive Functions and Psychological Factors in Patients with Severe COPD [Corrigendum]
Publicado: (2023)

Corrigendum to “Intraoperative Contrast Enhanced Ultrasound Evaluates the Grade of Glioma”
por: Cheng, Ling-Gang, et al.
Publicado: (2017)

The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia [Corrigendum]
Publicado: (2016)

Adapting Inhaled Medication Practice in COPD and Asthma to Avoid Funding the Tobacco Industry [Corrigendum]
Publicado: (2021)

Corrigendum to “Tentative study on radial endobronchial ultrasonography evaluating airway wall thickness before and after bronchial thermoplasty” [Respir. Med. Case Rep. 36 (2022) 101571]
por: Yan, Shang, et al.
Publicado: (2022)

Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study [Corrigendum]
Publicado: (2018)

Health behaviors and their correlates among participants in the Continuing to Confront COPD International Patient Survey [Corrigendum]
Publicado: (2017)

Ultrafine particles in airways: a novel marker of COPD exacerbation risk and inflammatory status [Corrigendum]
Publicado: (2019)

Inhaled Corticosteroid Treatment Regimens and Health Outcomes in a UK COPD Population Study [Corrigendum]
Publicado: (2020)

Corrigendum to “Acute Toxicity and Gastroprotective Role of M. pruriens in Ethanol-Induced Gastric Mucosal Injuries in Rats”
por: Golbabapour, Shahram, et al.
Publicado: (2018)

Low Eosinophil Phenotype Predicts Noninvasive Mechanical Ventilation Use in Patients with Hospitalized Exacerbations of COPD [Corrigendum]
Publicado: (2022)

Hospital Cost Savings for Sequential COPD Patients Receiving Domiciliary Nasal High Flow Therapy [Corrigendum]
Publicado: (2022)

The Short Physical Performance Battery is a discriminative tool for identifying patients with COPD at risk of disability [Corrigendum]
Publicado: (2016)

The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis [Corrigendum]
Publicado: (2018)

Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study [Corrigendum]
Publicado: (2019)

Impaired Training-Induced Adaptation of Blood Pressure in COPD Patients: Implication of the Muscle Capillary Bed [Corrigendum]
Publicado: (2020)

Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate [Corrigendum]
Publicado: (2021)

Corrigendum to “Gastroprotective Activity of Polygonum chinense Aqueous Leaf Extract on Ethanol-Induced Hemorrhagic Mucosal Lesions in Rats”
por: Ismail, Iza Farhana, et al.
Publicado: (2018)

Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study [Corrigendum]
Publicado: (2017)

The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes [Corrigendum]
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8f5pev448pnp2tfsuoqeud6uu5